Class Action Filed in New York Over Alleged Zantac NDMA Contamination
October 18, 2019 A proposed class action lawsuit has been filed over the possible contamination of heartburn treatment drug Zantac with dangerous levels of the probable carcinogen N-nitrosodimethylamine (NDMA).